Received Dec 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
rheumatoid arthritis; This spontaneous case was reported by an other health care professional and describes the occurrence of RHEUMATOID ARTHRITIS (rheumatoid arthritis) in an 8-decade-old male patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (rheumatoid arthritis) (seriousness criterion medically significant). At the time of the report, RHEUMATOID ARTHRITIS (rheumatoid arthritis) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. For SPIKEVAX NOS (SPIKEVAX NOS) (Unknown), the reporter did not provide any causality assessments. No concomitant medications provided by the reporter. It was reported that the patient age was in 70s. The patient never had the rheumatoid arthritis but post vaccination the patient experienced symptom of rheumatoid arthritis. Due to the symptom the patient quit work as an anesthesiologist. No treatment medications provided by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2021-004026 (E2B Linked Report).; Reporter's Comments: Company comment: Patient's elderly age is a confounder. The benefit-risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2021-004026:Master case (Reporter friend, Male patient)